Neil Davie

R&D

What do 300 million people have in common? They are living with rare diseases that are defined by their scarcity within the general population.

News

Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.